About Dr. Patel
I have the qualifications and experience to serve as an Investigator for the EDRN CVC. My areas of expertise include upper gastrointestinal malignancy (gastric, esophageal), hepatopancreaticobiliary malignancy, neuroendocrine tumors, sarcoma, and melanoma, and peritoneal surface malignancy and peritoneal carcinomatosis from GI or ovarian origin (HIPEC)…. My clinical research leadership includes serving as Contract PI for the clinical study Noncoding RNA Biomarkers for noninvasive and Early Detection of Pancreatic Cancer.
Associate Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
|2010||University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, MD, Doctor of Medicine|
|2006||University of Rochester, Rochester, NY, USA, BS, Cell and Developmental Biology, Minor in Health and Society|
|2013-2016||Clinical Fellowship, Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX|
|2010-2013||Clinical Residency, Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX|
|2016||Medical Oncology, American Board of Internal Medicine|
|2016||Hematology, American Board of Internal Medicine|
|2013||Internal Medicine, American Board of Internal Medicine|
Institutional Committee Activities
Member, Faculty Senate, 2020 - Present
Associate Scientific Member, Institutional Review Board 1, 2017 - 2020
|2010||AOA Medical Student Service Leadership Project Award|
- Patel S, Dowell J. Modern Management of Malignant Pleural Mesothelioma. Lung Cancer: Targets and Therapy 7:63-72, 2016.
- Patel S, Hamman H, Patel P, Schiller J. Comparison of Medical Oncologists' Approach to Non-Small Cell Lung Cancer Patients Compared with Breast Cancer. J Clin Oncol 31(suppl;abstr 6601), 2013.
- Patel S, Delrie R, Tam K, Abou Zahr A, Weil A, Tsai J, Frenkel E, Sarode R, Shen Y. Lupus Anticoagulant Screening Tests have Best Performance Characteristics for the Diagnosis of Antiphospholipid Syndrome. (2012), Proceedings of the Thrombosis and Hemostasis summit of North America 2012: Research abstracts. Am. J. Hematol 87:S146–S200, 2012.